• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report - Week of January 31, 2024

    FDA

    Mallinckrodt and Terumo BCT Announce Positive for Public Funding of UVADEX®

    PRNASIA

    Mallinckrodt, Terumo BCT announce UVADEX approval in Australia

    BIOSPECTRUMASIA

    Mallinckrodt and Terumo BCT Announce UVADEX® (Methoxsalen) Approved in Australia

    PRNASIA

    Actavis` Generic Methoxsalen (10Mg) Approved in US For Vitiligo

    FDA

    IDT Australia release on FDA nod for 23 generics begs the question: Where`s the beef?

    FIERCE PHARMA ASIA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.